journal article Apr 01, 2026

Author's reply—Cardiothoracic ratio in HFpEF: A mirror of heterogeneous pathophysiology

Journal of Cardiology Vol. 87 No. 4 pp. 395-396 · Elsevier BV
View at Publisher Save 10.1016/j.jjcc.2025.12.021
Topics

No keywords indexed for this article. Browse by subject →

References
5
[1]
Okada "Cardiothoracic ratio as a prognostic marker in heart failure with preserved ejection fraction" J Cardiol (2026) 10.1016/j.jjcc.2025.09.008
[2]
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert, Gabor Kovacs, Marius M Hoeper et al.

European Heart Journal 2022 10.1093/eurheartj/ehac237
[3]
Nagueh "Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging" Eur Heart J Cardiovasc Imaging (2016) 10.1093/ehjci/jew082
[4]
Sotomi "Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model" Heart (2023) 10.1136/heartjnl-2022-322181
[5]
Matsuoka "Phenotypic trajectories from acute to stable phase in heart failure with preserved ejection fraction: insights from the PURSUIT-HFpEF study" J Am Heart Assoc (2025) 10.1161/jaha.124.037567
Metrics
0
Citations
5
References
Details
Published
Apr 01, 2026
Vol/Issue
87(4)
Pages
395-396
License
View
Funding
Bristol-Myers Squibb Company
Fujifilm Toyama Chemical Co Ltd
Cite This Article
Masato Okada, Koichi Inoue, Yasushi Sakata (2026). Author's reply—Cardiothoracic ratio in HFpEF: A mirror of heterogeneous pathophysiology. Journal of Cardiology, 87(4), 395-396. https://doi.org/10.1016/j.jjcc.2025.12.021